Rakuten Investment Management Inc. purchased a new stake in Cigna Group (NYSE:CI – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund purchased 30,176 shares of the health services provider’s stock, valued at approximately $8,698,000.
Several other institutional investors have also recently made changes to their positions in CI. Wilsey Asset Management Inc. increased its stake in Cigna Group by 2.9% in the 2nd quarter. Wilsey Asset Management Inc. now owns 101,936 shares of the health services provider’s stock worth $33,698,000 after acquiring an additional 2,847 shares during the last quarter. SCS Capital Management LLC boosted its position in shares of Cigna Group by 39.1% during the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after acquiring an additional 8,609 shares during the last quarter. Retirement Systems of Alabama grew its holdings in shares of Cigna Group by 3.9% during the second quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after purchasing an additional 6,155 shares in the last quarter. Janney Montgomery Scott LLC increased its position in shares of Cigna Group by 3.9% in the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock worth $11,882,000 after purchasing an additional 1,357 shares during the last quarter. Finally, Natixis raised its stake in Cigna Group by 69.5% in the second quarter. Natixis now owns 223,884 shares of the health services provider’s stock valued at $74,012,000 after purchasing an additional 91,794 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Wall Street Analyst Weigh In
CI has been the subject of a number of research reports. Jefferies Financial Group reissued a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research note on Monday, November 3rd. Wolfe Research cut their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Truist Financial lifted their price target on Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research note on Monday, January 5th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a research report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $330.36.
Cigna Group Stock Up 1.3%
Shares of NYSE CI opened at $274.84 on Thursday. The firm has a market capitalization of $73.42 billion, a PE ratio of 12.12, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $274.07 and a two-hundred day simple moving average of $286.09. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the previous year, the business posted $7.51 EPS. The company’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts expect that Cigna Group will post 29.77 earnings per share for the current year.
Insider Buying and Selling
In other Cigna Group news, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.70% of the company’s stock.
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Wall Street Alert: Buy AES
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump’s Hand-Written Letter Will Shock his Haters
- Your Bank Account Is No Longer Safe
- Bitcoin is down but your income is about to explode
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
